Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrence

Figure 3

Western blot staining with anti-TRMT2A antibodies. a. Monoclonal antibody (S0722) directed at TRMT2A recognizes 38 Kd bands in five cell lines. b. Affinity purified polyclonal antibody (s0728) directed at a different, non-overlapping peptide in TRMT2A compared to the monoclonal also recognizes a 38 Kd band in the same cell lines. c. Polyclonal antibody to the same peptide as used to generate the monoclonal (s0545) stains only recombinant produced TRMT2A and not other recombinant proteins.

Back to article page